Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00904605 · ClinicalTrials.gov registry record · Phase 4
Lidocaine Patch Versus Celecoxib in Pain From Osteoarthritis of the Knee
A Phase 4 study, sponsored by Endo USA Inc., a Keenova Therapeutics Company.
- Terminated
- Registry status
- Phase 4
- Development phase
NCT00904605: Clinical Trial Phase 4 study, sponsored by Endo USA Inc., a Keenova Therapeutics Company.
NCT00904605 is a Phase 4 study that was terminated before completion, run by Endo USA Inc., a Keenova Therapeutics Company. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00904605, a Phase 4 study, was terminated before completion, sponsored by Endo USA Inc., a Keenova Therapeutics Company.
- TERMINATED
- Registry status
- Phase 4
- Development phase
Study Summary
Patients with unilateral or bilateral osteoarthritis of the knee participated in a Phase IV clinical trial to assess the efficacy of Lidoderm compared with celecoxib 200mg in treating pain from osteoarthritis of the knee.
Interventions
- DRUG Celecoxib
- DRUG Lidoderm
Trial Details
| Field | Value |
|---|---|
| Start Date | 2004-06 |
| Est. Completion | 2004-11 |
| Phase | Phase 4 |
Why NCT00904605 stopped before completion
NCT00904605 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which Celecoxib is the first listed.
NCT00904605 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00904605 about?
NCT00904605 is a clinical study titled "Lidocaine Patch Versus Celecoxib in Pain From Osteoarthritis of the Knee". Patients with unilateral or bilateral osteoarthritis of the knee participated in a Phase IV clinical trial to assess the efficacy of Lidoderm compared with celecoxib 200mg in treating pain from osteoarthritis of the knee.
What is the current status of trial NCT00904605?
This trial is currently terminated. It is a Phase 4 study. The study started on 2004-06. Estimated completion is 2004-11.
What interventions are being tested in trial NCT00904605?
The interventions under investigation include: Celecoxib (DRUG), Lidoderm (DRUG).
Who is sponsoring clinical trial NCT00904605?
This trial is sponsored by Endo USA Inc., a Keenova Therapeutics Company, which has 61 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia